Pictures Of Measles Virus - Articles

Sort by: Newest Most Comments Relevance

Measles virus derivatives boon for prostate cancer by Invisalign topdentist Posted Wed 04 Nov 2009 10:04pm Washington (IANS): Certain measles virus vaccine strain derivatives can effectively infect and kill prostate cancer cells. Prostate cancer is the second most common cause... study appeared in The Prostate. Source :- Measles virus derivatives boon for prostate cancer Read on »

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses by nih.gov Posted Sun 30 Aug 2009 5:00pm Description of Invention: The tick-borne encephalitis virus (TBEV) complex is a group of viruses that can cause severe neutrotropic disease and up to thirty percent (30%) mortality. While these viruses can be found in many parts of the world, the largest impact of the disease occurs in Europe and Russia, where approximately fourteen Read on »

Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine by nih.gov Posted Tue 30 Sep 2008 5:00pm Description of Invention: St. Louis Encephalitis Virus (SLEV) is a mosquito-borne flavivirus that is endemic in the Americas and causes sporadic outbreaks of disease in humans. SLEV is a member of the Japanese encephalitis virus serocomplex and is closely related to West Nile Virus (WNV). St. Louis encephalitis is found throughout Read on »

Three more cases of measles diagnosed in B.C.; What is measles? by ViaMedica Posted Wed 07 Apr 2010 12:00am KELOWNA, B.C. — Three cases of measles have been confirmed in the B.C. interior on the heels of a outbreak last month in the Metro Vancouver area. The Interior Health... travelled outside their communities. That means they can't be traced back to the measles outbreak in the Vancouver area, in which there were 10 confirmed cases of the disease, eight Read on »

Three more cases of measles diagnosed in B.C.; What is measles? by ViaMedica Posted Wed 07 Apr 2010 7:06am Read on »

CFS Virus Saga Continues – Murine Leukemia Virus or MLV Now Found by FDA and NIH by Chris H. Posted Mon 23 Aug 2010 3:38pm The chronic fatigue virus saga continues. Today, the NIH, FDA and CDC held a teleconference and provided additional evidence of an association between a virus and Chronic Fatigue Syndrome. But instead of focusing on XMRV like I thought they would, most of the call was centered on a virus called murine leukemia Read on »

Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses by nih.gov Posted Tue 30 Sep 2008 5:00pm relates to dengue virus mutations that may contribute to the development of improved dengue vaccines. Site directed and random mutagenesis techniques were used to introduce mutations into the dengue virus genome and to assemble a collection of useful mutations for incorporation in recombinant live attenuated dengue virus vaccines. The resulting mutant Read on »

Virus hits Genzyme plant – Virus Infected Hamster Ovary Cells by Medical Quack Patient Expert

Posted Wed 17 Jun 2009 10:45pm This is a little different as we all read about computer viruses so much, but this is a real contamination issue. The plant had issues back in 2008 with a warning letter... Genzyme shut down a Massachusetts factory after a virus infected hamster ovary cells used to produce Fabrazyme and Cerezyme, drugs for two rare genetic disorders. Genzyme Read on »

Live Attenuated Virus Vaccines for La Crosse Virus and Other Bunyaviridae by nih.gov Posted Sun 13 Jun 2010 5:00pm Description of Invention: La Crosse virus (LACV), family Bunyaviridae, is a mosquito-borne pathogen endemic in the United States. LACV infection results in 70–130... serologic studies estimate annual infection rates of 10–30/100,000 in endemic areas. LACV is a member of the California serogroup of viruses in the genus Orthobunyavirus Read on »

Recombinant Virus-Like Particle (VLP) and DNA Vaccines for Chikungunya Virus (CHIKV) and Other Alphaviruses by nih.gov Posted Sun 27 Feb 2011 7:00pm Description of Invention: Available for licensing and commercial development are compositions and methods of use as vaccines of virus-like particles (VLPs) expressing one or more Alphavirus capsid and envelope proteins, and in particular Chikungunya virus (CHIKV) core and envelope proteins. The invention also describes DNA, viral Read on »